Table 3.
Antibiotic resistance testing of Klebsiella pneumoniae.
| Total (n = 80) | Death group (n = 36) | Survival group (n = 44) | P-value | |
|---|---|---|---|---|
| CRKP (+) | 39 (48.8) | 26 (72.2) | 13 (29.5) | <0.001 |
| ESBL (+) | 41 (51.3) | 24 (66.7) | 17 (38.6) | 0.013 |
| Beta-lactam antibiotics, n (%) | ||||
| Piperacillin | 71 (88.8) | 35 (97.2) | 36 (81.8) | 0.070 |
| Ticarcillin | 75 (93.8) | 35 (97.2) | 40 (90.9) | 0.486 |
| Amoxicillin/clavulanic acid | 53 (66.3) | 31 (86.1) | 22 (50.0) | 0.001 |
| Piperacillin/tazobactam | 46 (57.5) | 29 (80.6) | 17 (38.6) | < 0.001 |
| Cefuroxim | 58 (72.5) | 32 (88.9) | 26 (59.1) | 0.003 |
| Ceftazidime | 48 (60.0) | 30 (83.3) | 18 (40.9) | < 0.001 |
| Cefepime | 47 (58.8) | 30 (83.3) | 17 (38.6) | < 0.001 |
| Aztreonam | 51 (63.8) | 30 (83.3) | 21 (47.7) | 0.001 |
| Imipenem | 39 (48.8) | 26 (72.2) | 13 (29.5) | < 0.001 |
| Meropenem | 39 (48.8) | 26 (72.2) | 13 (29.5) | < 0.001 |
| Fluoroquinolones, n (%) | ||||
| Ciprofloxacin | 55 (68.8) | 30 (83.3) | 25 (56.8) | 0.011 |
| Levofloxacin | 52 (65.0) | 29 (80.6) | 23 (52.3) | 0.008 |
| Moxifloxacin | 51 (63.8) | 29 (80.6) | 22 (50.0) | 0.005 |
| Sulfonamides, n (%) | ||||
| Compound sulfamethoxazole | 35 (43.8) | 19 (52.8) | 16 (36.4) | 0.141 |
| Tetracyclines, n (%) | ||||
| Tetracycline | 46 (57.5) | 26 (72.7) | 20 (45.5) | 0.016 |
| Tigecycline | 2 (2.5) | 2 (5.6) | 0 (0.0) | 0.199 |
| Aminoglycosides, n (%) | ||||
| Tobramycin | 50 (62.5) | 27 (75.0) | 23 (52.3) | 0.037 |
| Amikacin | 26 (32.5) | 16 (44.4) | 10 (22.7) | 0.039 |
CRKP, carbapenem-resistant Klebsiella pneumoniae.